Deloitte Legal (formerly Laga) assists MRM Health with a series A investment round by several investors

Taking on your challenges

21 February 2020

Deloitte Legal assisted MRM Health NV, a biopharmaceutical company focused on the discovery and development of innovative therapeutics based on the human microbiome, with a EUR 14 Million series A investment round by Ackermans & van Haaren, DuPont Nutrition & Biosciences, MRM Technologies, Qbic II and VIB.

Christoph Michiels and Jan De Poorter from the Corporate and M&A practice, together with Matthias Vierstraete from the Intellectual Property practice, comprised the team assisting in this transaction.

Read more in the press release issued by MRM Health

Did you find this useful?